缺血性视网膜病变 （ischemic retinopathy, IR），包括糖尿病性视网膜病变 （diabetic retinopathy, DR）、早产儿视网膜病变 （retinopathy of prematurity, ROP）和年龄相关性黄斑变性 （age-related macular degeneration, AMD），是失明的主要原因。异常血管生成是缺血性视网膜病变的关键过程，但其 ...

糖尿病视网膜病变（Diabetic Retinopathy，DR）的早期检测对于保护视力、预防视力恶化至关重要。眼底荧光血管造影（Fundus Fluorescein Angiography，FFA）作为诊断 DR 的金标准，能有效揭示视网膜血管的异常情况。然而，手动诊断 DR 不仅耗费人力、成本高昂，而且准确性 ...

Treating diabetic retinopathy (DR) is still a significant challenge for clinicians and remains a leading cause of blindness worldwide. NovaGo Therapeutics is developing a human antibody therapy ...

With the advent of the 21st century, healthcare practitioners have witnessed a dramatic increase in the number of people being diagnosed with diabetes globally. According to the International ...

“My laboratory and I are hopeful that our studies will reduce blindness in individuals with diabetic retinopathy and age-related macular degeneration,” Grant said. “We have been very fortunate to ...